Lonza Group AG Reports 1H Results
Lonza Welcomes New Group Chief Executive Officer Wolfgang Wienand
Acumen Pharmaceuticals Inc (ABOS) (Q1 2024) Earnings Call Transcript Highlights: Strategic ...
Earnings Call Summary | LONZA GROUP AG UNSP ADR EACH REP 0.1 ORD(LZAGY.US) Q1 2024 Earnings Conference
Q1 2024 Qualitative Update: Performance In Line With Expectations for Full-Year 2024
LONZA GROUP AG UNSP ADR EACH REP 0.1 ORD To Go Ex-Dividend On May 15th, 2024 With 0.22085 USD Dividend Per Share And 0.22085 USD Special Dividend Per Share
Lonza Prices EUR 1 Billion Straight Bond With a 3.875% Coupon
Lonza Group AG's (VTX:LONN) Largest Shareholders Are Individual Investors With 56% Ownership, Institutions Own 44%
Lonza Appoints New CEO
Swiss Healthcare Manufacturing Firm Lonza Bolsters Biologics Manufacturing Capacity With Roche's US Facility Acquisition For $1.2B
UPDATE 1-Luxury Stocks Drag European Equities Lower Ahead of Fed Meeting
UPDATE 1-Lonza to Buy Biologics Site From Roche in U.S. for $1.2 Bln
Lonza to Buy Biologics Site From Roche in U.S. for $1.2 Billion
Lonza Signs Agreement to Acquire Large-Scale Biologics Site in Vacaville (US) From Roche
Lonza Group's (VTX:LONN) Five-year Earnings Growth Trails the Favorable Shareholder Returns
Eli Lilly's Donanemab Nears Approval Decision, Could This Be a Turning Point in Alzheimer's Treatment?
Booming Weight-loss Drug Market to Lift "pick-and-shovel" Plays: Jefferies
Lonza Group AG (LZAGY) Q4 2023 Earnings Call Transcript Summary
Lonza Group AG Non-GAAP EPS of CHF12.39, Revenue of CHF6.72B
Lonza Names Heineken's Jean-Marc Huet as Next Chairman
No Data